FDA
-
-
-
-
-
-
-
PRIME SUBGROUP ANALYSIS DEMONSTRATES 22% REDUCTION IN NICU ADMISSIONS IN FIRST-TIME PREGNANCIES USING PreTRMĀ® Test-GUIDED CARE
-
-
-
-
-
-
-
SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION
-
-
-
-
-
-
-
Landmark Study Finds PreTRMĀ® Blood Test Reduces Earliest Preterm Births and Newborn Complications
-
-
-
-
-
-
-
SERA PROGNOSTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS
-
-
-
-
-
-
-
Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2025 Financial Results on May 7, 2025
-
-
-
-
-
-
-
Sera Prognostics (SERA) Announces Proposed Share Offering
-
-
-
-
-
-
-
SERA PROGNOSTICS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
-
330,004 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

